University of California San Francisco
Give to UCSF
In a study of 10 children published online in the American Journal of Human Genetics on April 14, the researchers linked a constellation of birth defects affecting the brain, eye, ear, heart and kidney to mutations in a single gene, called RERE.
Oncologist Lawrence Fong is leading UCSF’s newly launched Cancer Immunotherapy Program, a clinic and laboratory dedicated to developing and studying cutting-edge immunotherapy treatments.
Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.
Clinicians at UCSF are taking on trauma as more than just a social issue. They are addressing how it has a staggering impact on a person’s health.
UCSF and UC Hastings College of the Law have combined their expertise to offer a new degree program: the Masters of Science program in Health Policy and Law, which begins classes in August.
Bruce Alberts has been named one of the 11 newly elected fellows of the American Association for Cancer Research.
For more than 35 years, dentistry professor Mark Ryder has been devoted to engaging his students during long lectures. His trick: Performing magic routines to illustrate complex scientific concepts.
Mitchel Berger and Jeff Bluestone have been named to a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates that will help to guide the National Cancer Moonshot Initiative.
To keep a person's heart healthy, clinicians recommend avoiding risk factors such as smoking or excessive weight gain. But one risk factor, which cannot be changed, is being South Asian.
On April 5, 1941, a crowd all assembled to witness the laying of the cornerstone of California's first modern neuropsychiatric institute.
Nurse interactions with pharmaceutical and device companies are commonplace and beneficial, but they also can lead to conflicts of interest regarding drug treatment and purchasing decisions, according to researchers at UCSF.
The UCSF community is deeply saddened by the passing of Andrew S. Grove, former CEO and chairman of Intel Corp., who applied his drive for innovation to advocacy for advancements in health care and the treatment of cancer and Parkinson’s disease.
David O. Morgan, PhD, has been selected as the recipient of the 59th Annual Faculty Research Lectureship – Basic Science for his groundbreaking research on cell division.
This week, the Diabetes Center at UCSF announced that it has embarked on a precision medicine initiative with Yes Health, an all-mobile program to prevent type 2 diabetes.
For the third year in a row, UCSF's four schools — of Dentistry, Medicine, Nursing and Pharmacy — topped the nation in federal biomedical research funding in their fields, according to 2015 figures from the National Institutes of Health.
Learn more about some of the UCSF researchers who received the top funding from the National Institutes of Health in 2015.
Strengthening the link between Zika virus and microcephaly, scientists at UCSF have discovered that a protein the virus uses to infect skin cells and cause a rash is present also in stem cells of the developing human brain and retina.
An international team of scientists have for the first time identified genes and gene regulatory elements that are essential in wing development in the Natal long-fingered bat (Miniopterus natalensis), a species widely distributed in eastern and southern Africa.
